Virtue Capital Management, LLC Pfizer Inc Transaction History

Virtue Capital Management, LLC

$616 Million
Q3 2025

A detailed history of Virtue Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Virtue Capital Management, LLC holds 14,497 shares of PFE stock, worth $357,351. This represents 0.06% of its overall portfolio holdings.

Number of Shares

14,497

Previous 12,910 12.29%

Holding current value

$357,351

Previous $312,000 18.27%

% of portfolio

0.06%

Previous 0.06%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 31, 2025	BUY	$23.29 - $25.88 $36,961 - $41,071	1,587 Added 12.29%	14,497 $369,000
Q2 2025 Aug 13, 2025	SELL	$21.59 - $24.84 $259,554 - $298,626	-12,022 Reduced 48.22%	12,910 $312,000
Q1 2025 May 15, 2025	BUY	$25.01 - $27.13 $266,206 - $288,771	10,644 Added 74.5%	24,932 $631,000
Q4 2024 Feb 26, 2025	BUY	$24.8 - $30.19 $29,239 - $35,594	1,179 Added 8.99%	14,288 $379,000
Q3 2024 Nov 18, 2024	SELL	$27.7 - $31.39 $216,475 - $245,312	-7,815 Reduced 37.35%	13,109 $379,000
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $52,742 - $61,804	-2,088 Reduced 9.07%	20,924 $585,000
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $171,365 - $196,782	-6,619 Reduced 22.34%	23,012 $638,000
Q4 2023 Feb 15, 2024	SELL	$26.13 - $33.94 $165,977 - $215,586	-6,352 Reduced 17.65%	29,631 $853,000
Q2 2023 Jul 18, 2023	BUY	$36.12 - $41.79 $127,286 - $147,267	3,524 Added 10.86%	35,983 $1.32 Million
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $200,101 - $260,502	-5,080 Reduced 13.53%	32,459 $1.32 Million
Q4 2022 Feb 10, 2023	BUY	$41.75 - $54.5 $835,375 - $1.09 Million	20,009 Added 114.14%	37,539 $1.92 Million
Q3 2022 Nov 15, 2022	SELL	$43.76 - $53.42 $98,372 - $120,088	-2,248 Reduced 11.37%	17,530 $767,000
Q2 2022 Aug 10, 2022	SELL	$46.53 - $55.17 $883,883 - $1.05 Million	-18,996 Reduced 48.99%	19,778 $1.04 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $267,363 - $331,296	5,844 Added 17.75%	38,774 $2.01 Million
Q4 2021 Jan 24, 2022	SELL	$41.32 - $61.25 $55,575 - $82,381	-1,345 Reduced 3.92%	32,930 $1.95 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $157,000 - $201,680	4,000 Added 13.21%	34,275 $1.47 Million
Q2 2021 Jul 15, 2021	SELL	$35.91 - $40.68 $161,810 - $183,304	-4,506 Reduced 12.96%	30,275 $1.19 Million
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $15,472 - $17,449	462 Added 1.35%	34,781 $1.26 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $140,005 - $178,028	-4,183 Reduced 10.86%	34,319 $1.26 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $397,002 - $465,774	-12,504 Reduced 24.51%	38,502 $1.41 Million
Q2 2020 Aug 10, 2020	BUY	$30.12 - $36.54 $1.54 Million - $1.86 Million	51,006 New	51,006 $1.67 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $304,087 - $434,475	-11,250 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $1.09 Million - $1.24 Million	-33,210 Reduced 74.7%	11,250 $441,000
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $143,215 - $185,709	-4,408 Reduced 9.02%	44,460 $1.6 Million
Q2 2019 Nov 12, 2019	BUY	$36.98 - $41.52 $1.46 Million - $1.64 Million	39,572 Added 425.69%	48,868 $2.12 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $53,775 - $59,080	-1,434 Reduced 13.36%	9,296 $395,000
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $2.87 Million - $3.28 Million	-74,706 Reduced 87.44%	10,730 $468,000
Q3 2018 Feb 13, 2019	BUY	$34.47 - $41.81 $1.41 Million - $1.72 Million	41,032 Added 92.41%	85,436 $3.77 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $92,871 - $99,010	2,816 Added 6.77%	44,404 $1.61 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $105,494 - $122,388	3,306 Added 8.64%	41,588 $1.53 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $1.27 Million - $1.35 Million	38,282	38,282 $1.39 Million

Others Institutions Holding PFE

# of Institutions

3,314

Shares Held

3.65B

Call Options Held

96.6M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $138B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtue Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtue Capital Management, LLC with notifications on news.

Account

Virtue Capital Management, LLC Pfizer Inc Transaction History